Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Microencapsul. 2008 Sep;25(6):421-5. doi: 10.1080/02652040802033673.

Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity.

Author information

  • 1Department of Orthopaedics, St. Vincent's Hospital, VIC, Australia. crispin.dass@svhm.org.au

Abstract

DNAzymes are oligonucleotides capable of specific catalysis of target mRNA. To date, a delivery vehicle for DNAzymes has not been developed. Chitosan is a biomaterial obtained abundantly in nature. A biocompatible c-jun (an oncogene) DNAzyme nanoparticle formulated from chitosan was found to be more active against osteosarcoma (bone cancer) cells, inducing apoptotic cell death in these cells. The formulation was stable in serum for a week and at room temperature for a month. Clinically, knockdown of c-jun gene expression with chitosan nanobiotechnology may improve treatment outcome for tumours growing in bone.

PMID:
18465314
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Informa Healthcare
    Loading ...
    Write to the Help Desk